Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up safety trial of enalapril orodispersible minitablets in children with chronic heart failure
2015-002397-21Phase 3Completed
- Sponsor
- Ethicare Clinical Trial Services
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of enalapril in heart failure (HF), Heart failure due to congenital heart disease (HF-CHD) and Cardiovascular Malformation (CVM), sponsored by Ethicare Clinical Trial Services. Primary endpoint: Any adverse events. Started Sep 2015; status: completed.
02
Drugs
enalapril
03
Conditions
heart failure (HF)Heart failure due to congenital heart disease (HF-CHD)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2015-002397-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002397-21.